216 related articles for article (PubMed ID: 31929528)
1. Antileishmanial activity of Urtica dioica extract against zoonotic cutaneous leishmaniasis.
Badirzadeh A; Heidari-Kharaji M; Fallah-Omrani V; Dabiri H; Araghi A; Salimi Chirani A
PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007843. PubMed ID: 31929528
[TBL] [Abstract][Full Text] [Related]
2. Sambucus ebulus extract stimulates cellular responses in cutaneous leishmaniasis.
Heidari-Kharaji M; Fallah-Omrani V; Badirzadeh A; Mohammadi-Ghalehbin B; Nilforoushzadeh MA; Masoori L; Montakhab-Yeganeh H; Zare M
Parasite Immunol; 2019 Jan; 41(1):e12605. PubMed ID: 30472741
[TBL] [Abstract][Full Text] [Related]
3. Effects of negative air ions (NAIs) on Leishmania major: A novel tool for treatment of zoonotic cutaneous leishmaniasis (ZCL).
Badirzadeh A; Najm M; Hemphill A; Alipour M; Hasanpour H; Masoori L; Karimi P
PLoS One; 2022; 17(9):e0274124. PubMed ID: 36074764
[TBL] [Abstract][Full Text] [Related]
4. Stachys lavandulifolia Vahl. exhibits promising in vitro and in vivo antileishmanial activity against Leishmania major infection.
Alanazi AD; Albalawi AE; Almohammed HI; Shater AF
Trop Biomed; 2022 Sep; 39(3):412-420. PubMed ID: 36214438
[TBL] [Abstract][Full Text] [Related]
5. Leishmanicidal potentials of
Sharifi F; Sharififar F; Pournamdari M; Ansari M; Tavakoli Oliaee R; Bamorovat M; Khosravi A; Keyhani AR; Salarkia E; Mortazaeizdeh A; Dabiri S; Khamesipour A; Sharifi I
J Med Microbiol; 2021 Jun; 70(6):. PubMed ID: 34115583
[No Abstract] [Full Text] [Related]
6. The Therapeutic Effects of Curcumin-coated Gold Nanoparticle Against Leishmania Major Causative Agent of Zoonotic Cutaneous Leishmaniasis (ZCL): An In Vitro and In Vivo Study.
Amini SM; Hadighi R; Najm M; Alipour M; Hasanpour H; Vosoogh M; Vosough A; Hajizadeh M; Badirzadeh A
Curr Microbiol; 2023 Feb; 80(4):104. PubMed ID: 36781499
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of total phenolic fraction derived from extra virgin olive oil for its antileishmanial activity.
Koutsoni OS; Karampetsou K; Kyriazis ID; Stathopoulos P; Aligiannis N; Halabalaki M; Skaltsounis LA; Dotsika E
Phytomedicine; 2018 Aug; 47():143-150. PubMed ID: 30166099
[TBL] [Abstract][Full Text] [Related]
8. Immunogenic properties of empty pcDNA3 plasmid against zoonotic cutaneous leishmaniasis in mice.
Montakhab-Yeganeh H; Shafiei R; Najm M; Masoori L; Aspatwar A; Badirzadeh A
PLoS One; 2022; 17(2):e0263993. PubMed ID: 35167596
[TBL] [Abstract][Full Text] [Related]
9. Effect of
Mostafa G; Nahid J; Javad SS; Alireza D; Ebrahim SS
Ethiop J Health Sci; 2021 Mar; 31(2):401-408. PubMed ID: 34158792
[TBL] [Abstract][Full Text] [Related]
10. In-vitro and in-vivo comparative effects of the spring and autumn-harvested Artemisia aucheri Bioss extracts on Leishmania major.
KarimiPourSaryazdi A; Ghaffarifar F; Dalimi A; Dayer MS
J Ethnopharmacol; 2020 Jul; 257():112910. PubMed ID: 32344159
[TBL] [Abstract][Full Text] [Related]
11. Treatment with synthetic lipophilic tyrosyl ester controls Leishmania major infection by reducing parasite load in BALB/c mice.
Sghaier RM; Aissa I; Attia H; Bali A; Leon Martinez PA; Mkannez G; Guerfali FZ; Gargouri Y; Laouini D
Parasitology; 2016 Oct; 143(12):1615-21. PubMed ID: 27312247
[TBL] [Abstract][Full Text] [Related]
12. Immunostimulatory responses to crude extracts of Warburgia ugandensis (Sprague) subsp ugandensis (Canellaceae) by BALB/c mice infected with Leishmania major.
Ngure P; Ng'ang'a Z; Kimutai A; Kepha S; Mong'are S; Ingonga J; Tonui W
Pan Afr Med J; 2014; 17 Suppl 1(Suppl 1):15. PubMed ID: 24624248
[TBL] [Abstract][Full Text] [Related]
13. Fe3O4
Albalawi AE; Khalaf AK; Alyousif MS; Alanazi AD; Baharvand P; Shakibaie M; Mahmoudvand H
Biomed Pharmacother; 2021 Jul; 139():111566. PubMed ID: 33839494
[TBL] [Abstract][Full Text] [Related]
14. Skin-derived macrophages from Leishmania major-susceptible mice exhibit interleukin-12- and interferon-gamma-independent nitric oxide production and parasite killing after treatment with immunostimulatory DNA.
von Stebut E; Belkaid Y; Nguyen B; Wilson M; Sacks DL; Udey MC
J Invest Dermatol; 2002 Sep; 119(3):621-8. PubMed ID: 12230504
[TBL] [Abstract][Full Text] [Related]
15. Enhanced paromomycin efficacy by solid lipid nanoparticle formulation against Leishmania in mice model.
Heidari-Kharaji M; Taheri T; Doroud D; Habibzadeh S; Badirzadeh A; Rafati S
Parasite Immunol; 2016 Oct; 38(10):599-608. PubMed ID: 27213964
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of amiodarone in treatment of cutaneous leishmaniasis caused by Leishmania major.
Bemani E; Oryan A; Bahrami S
Exp Parasitol; 2019 Oct; 205():107747. PubMed ID: 31442454
[TBL] [Abstract][Full Text] [Related]
17. Anti-leishmanial effects of trinitroglycerin in BALB/C mice infected with Leishmania major via nitric oxide pathway.
Nahrevanian H; Najafzadeh M; Hajihosseini R; Nazem H; Farahmand M; Zamani Z
Korean J Parasitol; 2009 Jun; 47(2):109-15. PubMed ID: 19488416
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of anti-leishmanial activity by induction of nitric oxide and inhibition of prostaglandin in Balb/c mice infected with Leishmania major.
Nahrevanian H; Hajihosseini R; Arjmand M; Farahmand M; Ghasemi F
Southeast Asian J Trop Med Public Health; 2009 Nov; 40(6):1188-98. PubMed ID: 20578452
[TBL] [Abstract][Full Text] [Related]
19. S-nitrosoglutathione (GSNO) is cytotoxic to intracellular amastigotes and promotes healing of topically treated Leishmania major or Leishmania braziliensis skin lesions.
Costa IS; de Souza GF; de Oliveira MG; Abrahamsohn Ide A
J Antimicrob Chemother; 2013 Nov; 68(11):2561-8. PubMed ID: 23788476
[TBL] [Abstract][Full Text] [Related]
20. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA
Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
